RJA
CNL

Raymond James & Associates’s CLECO CRP (HOLDING CO) CNL Stock Holding History

Raymond James & Associates’s Portfolio CNL Stock Details CNL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-5,602
Closed -$309K – 3169
2016
Q1 		$309K Buy
+5,602
New +$285K ﹤0.01% 2310
2015
Q4 		– Sell
-20,038
Closed -$1.07M – 2445
2015
Q3 		$1.07M Buy
20,038
+657
+3% +$35.4K ﹤0.01% 1564
2015
Q2 		$1.04M Sell
19,381
-1,806
-9% -$98K ﹤0.01% 1717
2015
Q1 		$1.16M Sell
21,187
-5,437
-20% -$296K 0.01% 1576
2014
Q4 		$1.45M Buy
26,624
+2,409
+10% +$127K 0.01% 1335
2014
Q3 		$1.17M Buy
24,215
+1,733
+8% +$96K 0.01% 1405
2014
Q2 		$1.32M Buy
22,482
+3,075
+16% +$160K 0.01% 1325
2014
Q1 		$982K Buy
19,407
+103
+0.5% +$4.99K 0.01% 1431
2013
Q4 		$900K Sell
19,304
-186
-1% -$8.55K 0.01% 1385
2013
Q3 		$874K Buy
19,490
+54
+0.3% +$2.52K 0.01% 1326
2013
Q2 		$902K Buy
+19,436
New +$908K 0.01% 1221

Other funds holding CNL

RCM
Riverhead Capital Management Wilmington, Delaware $2.71B AUM 2.34% 1-Year Est. Return

Raymond James & Associates's CNL Position: Q2 2016 in Review

Raymond James & Associates sold out of CLECO CRP (HOLDING CO) (CNL) in Q2 2016, closing a stake of 5,602 shares — an estimated $309K sold.

Raymond James & Associates first reported a position in CNL in Q2 2013 and held it in 11 quarters. The position peaked at $1.45M in Q4 2014. 1 fund tracked by Wall St. Rank holds CNL as of Q2 2016.

  • Raymond James & Associates reported no remaining CLECO CRP (HOLDING CO) position as of Q2 2016 after selling out during the quarter.
  • Raymond James & Associates sold 5,602 CLECO CRP (HOLDING CO) shares in Q2 2016, an estimated $309K.
  • Raymond James & Associates first reported a position in CLECO CRP (HOLDING CO) in Q2 2013 and held it in 11 quarters.
  • Raymond James & Associates's CLECO CRP (HOLDING CO) position peaked at $1.45M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held CLECO CRP (HOLDING CO) as of Q2 2016.

Based on Raymond James & Associates's 13F filing for Q2 2016, filed 11 Aug 2016.